show
highest
rate
cure
case
confirm
case
lowest
averag
rate
sever
case
one
death
treatment
capac
strongli
affect
region
econom
measur
control
detect
treatment
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
implic
avail
evid
chines
experi
provid
import
insight
design
effect
manag
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
deliv
array
cybersecur
challeng
ie
overload
healthcar
system
disrupt
socioeconom
system
global
respons
epidem
present
strength
weak
nation
region
social
govern
capac
address
public
health
challeng
emerg
detect
spread
treatment
contain
infecti
diseas
show
consider
polit
econom
impact
highli
interconnect
world
understand
socioeconom
level
respond
spread
treatment
covid
great
signific
success
combat
coronaviru
epidem
social
econom
circumst
affect
spread
treatment
infecti
diseas
convent
social
govern
measur
travel
ban
social
distanc
gather
reduct
play
major
role
prevent
control
rapid
spread
epidem
respons
public
health
emerg
continu
immedi
spread
migrationthi
case
wuhan
china
begin
pandem
case
china
world
popul
migrat
mobil
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
link
increas
econom
growth
wage
incom
innov
well
viru
spread
lockdown
citi
adopt
mani
countri
success
wuhan
close
januari
measur
aim
mitig
spread
disrupt
health
care
system
led
low
rate
cure
high
sever
mortal
rate
patient
furthermor
pandem
like
caus
disrupt
basic
medic
servic
emerg
facil
deprioritis
treatment
lifethreaten
diseas
condit
chronic
infecti
diseas
eg
cardiovascular
cerebrovascular
diseas
tuberculosi
malign
everywher
especi
develop
economi
health
system
alreadi
fragil
thu
improv
understand
spread
treatment
capac
affect
socioeconom
level
crucial
examin
effect
control
intervent
studi
aim
estim
effect
socioeconom
level
spread
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
market
symptom
sever
case
classifi
mild
sever
critic
mild
case
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
sharpli
februari
worker
start
return
work
nationwid
outsid
hubei
start
februari
respons
level
public
health
downgrad
outsid
hubei
chines
govern
adopt
intens
measur
contain
ie
wuhan
lockdown
movement
restrict
home
selfisol
mask
public
nation
joint
prevent
control
inform
disclosur
time
suffici
detect
mask
public
protect
oneself
infect
sinc
prove
transmit
mainli
droplet
wear
mask
effect
prevent
viru
transmiss
nation
joint
prevent
control
launch
commun
level
inform
transpar
guarante
e
realtim
announc
number
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
relationship
migrat
citi
confirm
case
china
outsid
hubei
provinc
examin
daili
migrat
scale
index
citi
januari
respect
calcul
compar
select
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
tempor
chang
rate
sever
case
obtain
use
excel
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
top
five
provinc
growth
rate
confirm
case
indic
decreas
order
zhejiang
guangdong
henan
hunan
jiangxi
provinc
figur
tempor
spatial
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
subperiod
figur
associ
social
manag
measur
figur
specif
first
subperiod
onset
januari
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
china
low
level
peak
incid
per
capita
earli
time
peak
effect
control
case
number
suggest
manag
measur
associ
delay
outbreak
notabl
declin
case
number
china
provinc
rate
sever
case
region
close
exceed
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
unit
state
itali
spain
becom
epicent
present
countri
seriou
epidem
also
adopt
intens
measur
eg
lockdown
wear
mask
public
social
distanc
detect
inform
disclosur
control
revers
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
guangdong
second
largest
provinc
provid
medic
assist
hubei
nevertheless
number
confirm
case
guangdong
largest
rate
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
key
find
socioeconom
level
strong
effect
spread
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
conflict
interest
declar
conflict
interest
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
